aluates Reports

$ 0.0

Automative

Global Gastrointestinal Market Research Report 2026

Published Date: 2026-01-30

Report Code: QYRE-Auto-3O396

Global Gastrointestinal Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Gastrointestinal Market Research Report 2026

Code: QYRE-Auto-3O396

Report

2026-01-30

Pages:111

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AstraZenec

Sanofi

Bayer

Pfizer Inc

Zeria（Tillotts）

Perrigo

Boehringer Ingelheim

Purdue Pharma

C.B. Fleet

Abbott

Jiangzhong

Xian Janssen

GlaxoSmithKline

GlaxoSmithKline PLC

TEVA

Gastrointestinal Market Size

The global Gastrointestinal market was valued at US$ 38160 million in 2025 and is anticipated to reach US$ 47750 million by 2032, at a CAGR of 3.3% from 2026 to 2032.

Gastrointestinal Market

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn"s disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.

Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.

Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.

In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.

This report delivers a comprehensive overview of the global Gastrointestinal market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gastrointestinal. The Gastrointestinal market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Gastrointestinal market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Gastrointestinal manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Gastrointestinal Market Report

Report Metric	Details
Report Name	Gastrointestinal Market
Accounted market size in 2025	US$ 38160 million
Forecasted market size in 2032	US$ 47750 million
CAGR	3.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Prescription Gastrointestinal Drug OTC Gastrointestinal Drug
Segment by Application	Chronic Gastritis Functional Dyspepsia Peptic Ulcer Acute Gastroenteritis Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Gastrointestinal companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Gastrointestinal Market growing?

Ans: The Gastrointestinal Market witnessing a CAGR of 3.3% during the forecast period 2026-2032.

What is the Gastrointestinal Market size in 2032?

Ans: The Gastrointestinal Market size in 2032 will be US$ 47750 million.

What is the market share of major companies in Gastrointestinal Market?

Ans: Global top five manufacturers hold a share over 25%.

What is the Gastrointestinal Market share by type?

Ans: In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%.

Who are the main players in the Gastrointestinal Market report?

Ans: The main players in the Gastrointestinal Market are AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen

What are the Application segmentation covered in the Gastrointestinal Market report?

Ans: The Applications covered in the Gastrointestinal Market report are Chronic Gastritis, Functional Dyspepsia, Peptic Ulcer, Acute Gastroenteritis, Others

What are the Type segmentation covered in the Gastrointestinal Market report?

Ans: The Types covered in the Gastrointestinal Market report are Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gastrointestinal Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Prescription Gastrointestinal Drug

1.2.3 OTC Gastrointestinal Drug

1.3 Market by Application

1.3.1 Global Gastrointestinal Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Chronic Gastritis

1.3.3 Functional Dyspepsia

1.3.4 Peptic Ulcer

1.3.5 Acute Gastroenteritis

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gastrointestinal Market Perspective (2021–2032)

2.2 Global Gastrointestinal Growth Trends by Region

2.2.1 Global Gastrointestinal Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Gastrointestinal Historic Market Size by Region (2021–2026)

2.2.3 Gastrointestinal Forecasted Market Size by Region (2027–2032)

2.3 Gastrointestinal Market Dynamics

2.3.1 Gastrointestinal Industry Trends

2.3.2 Gastrointestinal Market Drivers

2.3.3 Gastrointestinal Market Challenges

2.3.4 Gastrointestinal Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gastrointestinal Players by Revenue

3.1.1 Global Top Gastrointestinal Players by Revenue (2021–2026)

3.1.2 Global Gastrointestinal Revenue Market Share by Players (2021–2026)

3.2 Global Top Gastrointestinal Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Gastrointestinal Revenue

3.4 Global Gastrointestinal Market Concentration Ratio

3.4.1 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Revenue in 2025

3.5 Global Key Players of Gastrointestinal Head Offices and Areas Served

3.6 Global Key Players of Gastrointestinal, Products and Applications

3.7 Global Key Players of Gastrointestinal, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Gastrointestinal Breakdown Data by Type

4.1 Global Gastrointestinal Historic Market Size by Type (2021–2026)

4.2 Global Gastrointestinal Forecasted Market Size by Type (2027–2032)

5 Gastrointestinal Breakdown Data by Application

5.1 Global Gastrointestinal Historic Market Size by Application (2021–2026)

5.2 Global Gastrointestinal Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Gastrointestinal Market Size (2021–2032)

6.2 North America Gastrointestinal Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Gastrointestinal Market Size by Country (2021–2026)

6.4 North America Gastrointestinal Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gastrointestinal Market Size (2021–2032)

7.2 Europe Gastrointestinal Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Gastrointestinal Market Size by Country (2021–2026)

7.4 Europe Gastrointestinal Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Gastrointestinal Market Size (2021–2032)

8.2 Asia-Pacific Gastrointestinal Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Gastrointestinal Market Size by Region (2021–2026)

8.4 Asia-Pacific Gastrointestinal Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Gastrointestinal Market Size (2021–2032)

9.2 Latin America Gastrointestinal Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Gastrointestinal Market Size by Country (2021–2026)

9.4 Latin America Gastrointestinal Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gastrointestinal Market Size (2021–2032)

10.2 Middle East & Africa Gastrointestinal Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Gastrointestinal Market Size by Country (2021–2026)

10.4 Middle East & Africa Gastrointestinal Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZenec

11.1.1 AstraZenec Company Details

11.1.2 AstraZenec Business Overview

11.1.3 AstraZenec Gastrointestinal Introduction

11.1.4 AstraZenec Revenue in Gastrointestinal Business (2021–2026)

11.1.5 AstraZenec Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Gastrointestinal Introduction

11.2.4 Sanofi Revenue in Gastrointestinal Business (2021–2026)

11.2.5 Sanofi Recent Development

11.3 Bayer

11.3.1 Bayer Company Details

11.3.2 Bayer Business Overview

11.3.3 Bayer Gastrointestinal Introduction

11.3.4 Bayer Revenue in Gastrointestinal Business (2021–2026)

11.3.5 Bayer Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Gastrointestinal Introduction

11.4.4 Pfizer Revenue in Gastrointestinal Business (2021–2026)

11.4.5 Pfizer Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Gastrointestinal Introduction

11.5.4 GlaxoSmithKline Revenue in Gastrointestinal Business (2021–2026)

11.5.5 GlaxoSmithKline Recent Development

11.6 Teva

11.6.1 Teva Company Details

11.6.2 Teva Business Overview

11.6.3 Teva Gastrointestinal Introduction

11.6.4 Teva Revenue in Gastrointestinal Business (2021–2026)

11.6.5 Teva Recent Development

11.7 Zeria（Tillotts）

11.7.1 Zeria（Tillotts） Company Details

11.7.2 Zeria（Tillotts） Business Overview

11.7.3 Zeria（Tillotts） Gastrointestinal Introduction

11.7.4 Zeria（Tillotts） Revenue in Gastrointestinal Business (2021–2026)

11.7.5 Zeria（Tillotts） Recent Development

11.8 Perrigo

11.8.1 Perrigo Company Details

11.8.2 Perrigo Business Overview

11.8.3 Perrigo Gastrointestinal Introduction

11.8.4 Perrigo Revenue in Gastrointestinal Business (2021–2026)

11.8.5 Perrigo Recent Development

11.9 Boehringer Ingelheim

11.9.1 Boehringer Ingelheim Company Details

11.9.2 Boehringer Ingelheim Business Overview

11.9.3 Boehringer Ingelheim Gastrointestinal Introduction

11.9.4 Boehringer Ingelheim Revenue in Gastrointestinal Business (2021–2026)

11.9.5 Boehringer Ingelheim Recent Development

11.10 Purdue Pharma

11.10.1 Purdue Pharma Company Details

11.10.2 Purdue Pharma Business Overview

11.10.3 Purdue Pharma Gastrointestinal Introduction

11.10.4 Purdue Pharma Revenue in Gastrointestinal Business (2021–2026)

11.10.5 Purdue Pharma Recent Development

11.11 C.B. Fleet

11.11.1 C.B. Fleet Company Details

11.11.2 C.B. Fleet Business Overview

11.11.3 C.B. Fleet Gastrointestinal Introduction

11.11.4 C.B. Fleet Revenue in Gastrointestinal Business (2021–2026)

11.11.5 C.B. Fleet Recent Development

11.12 Abbott

11.12.1 Abbott Company Details

11.12.2 Abbott Business Overview

11.12.3 Abbott Gastrointestinal Introduction

11.12.4 Abbott Revenue in Gastrointestinal Business (2021–2026)

11.12.5 Abbott Recent Development

11.13 Jiangzhong

11.13.1 Jiangzhong Company Details

11.13.2 Jiangzhong Business Overview

11.13.3 Jiangzhong Gastrointestinal Introduction

11.13.4 Jiangzhong Revenue in Gastrointestinal Business (2021–2026)

11.13.5 Jiangzhong Recent Development

11.14 Xian-Janssen

11.14.1 Xian-Janssen Company Details

11.14.2 Xian-Janssen Business Overview

11.14.3 Xian-Janssen Gastrointestinal Introduction

11.14.4 Xian-Janssen Revenue in Gastrointestinal Business (2021–2026)

11.14.5 Xian-Janssen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AstraZenec

Sanofi

Bayer

Pfizer Inc

Zeria（Tillotts）

Perrigo

Boehringer Ingelheim

Purdue Pharma

C.B. Fleet

Abbott

Jiangzhong

Xian Janssen

GlaxoSmithKline

GlaxoSmithKline PLC

TEVA

List of Tables

Table 1. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Prescription Gastrointestinal Drug

Table 3. Key Players of OTC Gastrointestinal Drug

Table 4. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Gastrointestinal Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Gastrointestinal Market Size by Region (US$ Million), 2021–2026

Table 7. Global Gastrointestinal Market Share by Region (2021–2026)

Table 8. Global Gastrointestinal Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Gastrointestinal Market Share by Region (2027–2032)

Table 10. Gastrointestinal Market Trends

Table 11. Gastrointestinal Market Drivers

Table 12. Gastrointestinal Market Challenges

Table 13. Gastrointestinal Market Restraints

Table 14. Global Gastrointestinal Revenue by Players (US$ Million), 2021–2026

Table 15. Global Gastrointestinal Market Share by Players (2021–2026)

Table 16. Global Top Gastrointestinal Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gastrointestinal Revenue, 2025

Table 17. Ranking of Global Top Gastrointestinal Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Gastrointestinal Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Gastrointestinal, Headquarters and Area Served

Table 20. Global Key Players of Gastrointestinal, Products and Applications

Table 21. Global Key Players of Gastrointestinal, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Gastrointestinal Market Size by Type (US$ Million), 2021–2026

Table 24. Global Gastrointestinal Revenue Market Share by Type (2021–2026)

Table 25. Global Gastrointestinal Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Gastrointestinal Revenue Market Share by Type (2027–2032)

Table 27. Global Gastrointestinal Market Size by Application (US$ Million), 2021–2026

Table 28. Global Gastrointestinal Revenue Market Share by Application (2021–2026)

Table 29. Global Gastrointestinal Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Gastrointestinal Revenue Market Share by Application (2027–2032)

Table 31. North America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Gastrointestinal Market Size by Country (US$ Million), 2021–2026

Table 33. North America Gastrointestinal Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Gastrointestinal Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Gastrointestinal Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Gastrointestinal Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Gastrointestinal Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Gastrointestinal Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Gastrointestinal Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Gastrointestinal Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Gastrointestinal Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Gastrointestinal Market Size by Country (US$ Million), 2027–2032

Table 46. AstraZenec Company Details

Table 47. AstraZenec Business Overview

Table 48. AstraZenec Gastrointestinal Product

Table 49. AstraZenec Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 50. AstraZenec Recent Development

Table 51. Sanofi Company Details

Table 52. Sanofi Business Overview

Table 53. Sanofi Gastrointestinal Product

Table 54. Sanofi Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 55. Sanofi Recent Development

Table 56. Bayer Company Details

Table 57. Bayer Business Overview

Table 58. Bayer Gastrointestinal Product

Table 59. Bayer Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 60. Bayer Recent Development

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer Gastrointestinal Product

Table 64. Pfizer Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 65. Pfizer Recent Development

Table 66. GlaxoSmithKline Company Details

Table 67. GlaxoSmithKline Business Overview

Table 68. GlaxoSmithKline Gastrointestinal Product

Table 69. GlaxoSmithKline Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 70. GlaxoSmithKline Recent Development

Table 71. Teva Company Details

Table 72. Teva Business Overview

Table 73. Teva Gastrointestinal Product

Table 74. Teva Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 75. Teva Recent Development

Table 76. Zeria（Tillotts） Company Details

Table 77. Zeria（Tillotts） Business Overview

Table 78. Zeria（Tillotts） Gastrointestinal Product

Table 79. Zeria（Tillotts） Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 80. Zeria（Tillotts） Recent Development

Table 81. Perrigo Company Details

Table 82. Perrigo Business Overview

Table 83. Perrigo Gastrointestinal Product

Table 84. Perrigo Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 85. Perrigo Recent Development

Table 86. Boehringer Ingelheim Company Details

Table 87. Boehringer Ingelheim Business Overview

Table 88. Boehringer Ingelheim Gastrointestinal Product

Table 89. Boehringer Ingelheim Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 90. Boehringer Ingelheim Recent Development

Table 91. Purdue Pharma Company Details

Table 92. Purdue Pharma Business Overview

Table 93. Purdue Pharma Gastrointestinal Product

Table 94. Purdue Pharma Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 95. Purdue Pharma Recent Development

Table 96. C.B. Fleet Company Details

Table 97. C.B. Fleet Business Overview

Table 98. C.B. Fleet Gastrointestinal Product

Table 99. C.B. Fleet Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 100. C.B. Fleet Recent Development

Table 101. Abbott Company Details

Table 102. Abbott Business Overview

Table 103. Abbott Gastrointestinal Product

Table 104. Abbott Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 105. Abbott Recent Development

Table 106. Jiangzhong Company Details

Table 107. Jiangzhong Business Overview

Table 108. Jiangzhong Gastrointestinal Product

Table 109. Jiangzhong Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 110. Jiangzhong Recent Development

Table 111. Xian-Janssen Company Details

Table 112. Xian-Janssen Business Overview

Table 113. Xian-Janssen Gastrointestinal Product

Table 114. Xian-Janssen Revenue in Gastrointestinal Business (US$ Million), 2021–2026

Table 115. Xian-Janssen Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Gastrointestinal Picture

Figure 2. Global Gastrointestinal Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Gastrointestinal Market Share by Type: 2025 vs 2032

Figure 4. Prescription Gastrointestinal Drug Features

Figure 5. OTC Gastrointestinal Drug Features

Figure 6. Global Gastrointestinal Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Gastrointestinal Market Share by Application: 2025 vs 2032

Figure 8. Chronic Gastritis Case Studies

Figure 9. Functional Dyspepsia Case Studies

Figure 10. Peptic Ulcer Case Studies

Figure 11. Acute Gastroenteritis Case Studies

Figure 12. Others Case Studies

Figure 13. Gastrointestinal Report Years Considered

Figure 14. Global Gastrointestinal Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Gastrointestinal Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Gastrointestinal Market Share by Region: 2025 vs 2032

Figure 17. Global Gastrointestinal Market Share by Players in 2025

Figure 18. Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Revenue in 2025

Figure 20. North America Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Gastrointestinal Market Share by Country (2021–2032)

Figure 22. United States Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Gastrointestinal Market Share by Country (2021–2032)

Figure 26. Germany Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Gastrointestinal Market Share by Region (2021–2032)

Figure 34. China Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Gastrointestinal Market Share by Country (2021–2032)

Figure 42. Mexico Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Gastrointestinal Market Share by Country (2021–2032)

Figure 46. Israel Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. AstraZenec Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 50. Sanofi Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 51. Bayer Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 52. Pfizer Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 53. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 54. Teva Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 55. Zeria（Tillotts） Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 56. Perrigo Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 57. Boehringer Ingelheim Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 58. Purdue Pharma Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 59. C.B. Fleet Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 60. Abbott Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 61. Jiangzhong Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 62. Xian-Janssen Revenue Growth Rate in Gastrointestinal Business (2021–2026)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gastrointestinal Therapeutics Market Research Report 2024

Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Research Report 2024

Global Prescription Gastrointestinal Drugs Market Research Report 2024

Irritable Bowel Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Digestive Drugs Market Insights Forecast to 2030

Gastrointestinal Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global OTC Gastrointestinal Products Market Research Report 2024

Global Gastrointestinal OTC Drugs Market Research Report 2024

Global Irritable Bowel Syndrome IBS Market Insights Forecast to 2030

Irritable Bowel Syndrome Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inflammatory Bowel Disease Relief Market Insights Forecast to 2030

Global Digestive Remedies Market Research Report 2024

Global Crohn s Disease Diagnostic and Therapeutic Market Insights Forecast to 2030

Global OTC Digestives and Intestinal Remedies Market Research Report 2024

Irritable Bowel Syndrome IBS Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gastrointestinal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inflammatory Bowel Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastroenterology Devices Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions